SciRhom
SciRhom develops multi-target humanized antibodies against iRhom2 to treat autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease.
AutonomUS Medical Technologies Inc.
AutonomUS Medical Technologies Inc. has developed artificial intelligence (AI)-enabled ultrasound-guided surgical robotic devices for diverse diagnostic and therapeutic applications.
Regel Therapeutics
Regel Therapeutics uses targeted genome binding to restore gene expression in haploinsufficient disorders. The initial company focus is on neuronal and muscular diseases.
Tevard Bioscience
Tevard Biosciences has three novel tRNA-based platform technologies to durably treat rare genetic disease.